Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)
China · Delayed Price · Currency is CNY 28.99
+1.08 (3.87%)
At close: Feb 13, 2026
SHE:300878 Market Cap
SHE:300878 has a market cap or net worth of 4.12 billion as of February 13, 2026. Its market cap has increased by 99.24% in one year.
Market Cap
4.12B
Enterprise Value
4.14B
Revenue
131.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.99
Market Cap Chart
Since August 24, 2020, SHE:300878's market cap has decreased from 6.52B to 4.12B, a decrease of -36.83%. That is a compound annual growth rate of -8.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 4.12B | 13.64% |
| Dec 31, 2025 | 3.62B | 69.28% |
| Dec 31, 2024 | 2.14B | -41.72% |
| Dec 29, 2023 | 3.67B | 2.30% |
| Dec 30, 2022 | 3.59B | -15.42% |
| Dec 31, 2021 | 4.25B | 4.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Obio Technology (Shanghai) Corp. | 4.52B |
| Hinova Pharmaceuticals | 4.50B |
| Zhejiang Shouxiangu Pharmaceutical | 4.17B |
| Guanhao Biotech | 4.15B |
| Boji Medical Technology | 4.07B |
| Qingdao Vland Biotech INC. | 4.01B |
| Shenzhen Bioeasy Biotechnology | 4.00B |
| Baolingbao Biology | 3.97B |